Skizofrénia: vizsgálatok itt: Románia
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Bucharest, Cluj-Napoca, Iasi, Timișoara
- Életkor
- 5 év to 17 év
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Where
- Bucharest, Galati, Sibiu
- Életkor
- 55 év and over
- People
- 370 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833 - 3. fázisTaking peopleRelapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Where
- Bucharest
- Életkor
- 18 év to 65 év
- People
- 472 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07686263 · EU 2025-523664-20-00 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Bucharest, Bucuresti, Constanța, Craiova, Oradea, Sibiu
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Where
- Bucharest, Cluj-Napoca, Iasi, Timișoara
- Életkor
- 13 év to 17 év
- People
- 166 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07288567 · EU 2025-523711-11-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Bragadiru, Bucharest, Caracal, Jassi
- Életkor
- 55 év to 90 év
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - 3. fázisTaking peopleNBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Where
- Brasov, Bucharest, Jassi, Sanpetru
- Életkor
- 18 év to 65 év
- People
- 284 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07105098 · EU 2025-521215-39-00 - 3. fázisTaking peopleNBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Where
- Bucharest, Jassi, Sanpetru
- Életkor
- 18 év to 65 év
- People
- 600 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07114874 · EU 2025-521216-19-00 - 3. fázisTaking peopleTrial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
- Where
- Brasov, Bucharest, Galati, Jassi, Oradea, Sanpetru, Sibiu, Târgu Mureş
- Életkor
- 18 év to 74 év
- People
- 450 worldwide
- Run by
- Otsuka Pharmaceutical Co., Ltd.
See details and how to joinNCT05325645 · EU 2022-500583-36-00 - 2. fázisTaking peopleA Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLUTION study)
- Where
- Bucharest, Cluj-Napoca, Jassi, Selimbar, Sibiu
- Életkor
- 18 év to 64 év
- People
- 239 worldwide
- Run by
- Oryzon Genomics S.A.
See details and how to join2023-507372-42-00 · EU 2023-507372-42-00 - 3. fázisTaking peopleRandomized, double-blind, placebo-controlled trial to evaluate efficacy and safety of Roluperidone in adults with negative symptoms of schizophrenia
- Where
- Brasov, Bucharest, Galati, Jassi, Sanpetru
- Életkor
- 18 év to 64 év
- People
- 120 worldwide
- Run by
- Minerva Neurosciences Inc.
See details and how to join2026-525925-19-00 · EU 2026-525925-19-00 - 2. fázisCsak meghívásosAn Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
- Where
- Bragadiru, Bucharest, Caracal
- Életkor
- 55 év to 91 év
- People
- 210 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT07459660 · EU 2025-521757-16-00 - 2. fázisTaking peopleEvaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
- Where
- Bucharest, Jassi, Târgu Mureş
- Életkor
- 18 év to 55 év
- People
- 120 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07288333 · EU 2025-521868-35-00 - 4. fázisTaking peopleClinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
- Where
- Cluj-Napoca
- Életkor
- 16 év to 70 év
- People
- 2500 worldwide
- Run by
- Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00 - 3. fázisTaking peopleEfficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- Where
- Timișoara
- Életkor
- 13 év to 17 év
- People
- 330 worldwide
- Run by
- Gedeon Richter Plc.
See details and how to joinNCT03817502 · EU 2024-513194-44-00